MedAdvisor Stock

MedAdvisor Debt/EBITDA

Delisted

The Total Debt to EBITDA Ratio of MedAdvisor (MDR.AX) as of Aug 5, 2026 is -1.76. In the previous year, Total Debt to EBITDA Ratio was 4.09 — a change of -143.14% (lower).

Debt/EBITDA

-1.76

YoY

-143.14%

Last updated:

Total Debt to EBITDA Ratio of MedAdvisor is 2026 -1.76 . Total Debt to EBITDA Ratio of MedAdvisor was 2025 4.09 . It decreases by -143.14% lower compared to the previous year.
Access this data via the Eulerpool API

MedAdvisor Stock analysis

What does MedAdvisor do? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedAdvisor stock

Total Debt to EBITDA Ratio of MedAdvisor is -1.76 in 2026.

Total Debt to EBITDA Ratio of MedAdvisor changed from 4.09 to -1.76, representing a -143.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio MedAdvisor since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's MedAdvisor with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — MedAdvisor

All Key Metrics — MedAdvisor